Karen Strauss, chief marketing and growth officer at M Booth Health, has exited the Next 15 Communications unit to launch her own firm.
At M Booth Health, she handled branding, thought leadership, external communications and business expansion.
Strauss joined M Booth Health in 2020 as chief strategy & innovation officer and co-led its Pharma Brandemic study that tracks attitudes and behaviors toward pharmaceutical brands.
Prior to M Booth Health, Strauss worked at Ketchum as EVP & executive creative director/healthcare; chief global strategy & creative officer; and chief innovation officer.
While at the Omnicom property, she led campaigns for Pfizer, AstraZeneca, Cleveland Clinic, Roche, American Express, Chase, Hershey, Whirlpool, Heinz and Mars.
"After nearly four decades working for agencies, I've formed my own communications consultancy," Strauss told O'Dwyer's.
She described Karen Strauss Communications LLC as a firm that "believes well-chosen words have the power to distinguish individuals, brands and companies; catapult leaders to fame; and win business, recognition and followers." The firm provides services in brand & profile building, thought leadership strategy & writing, and creative concepting & facilitation.
Stacey Bernstein, who was executive VP & global director at Weber Shandwick, succeeded Tim Bird as M Booth Health CEO in January. She reports to Dale Bornstein, CEO of M Booth.
She recruited Weber Shandwick alum Peter Matheson Gay as chief impact officer in March.
M Booth Health ranks No. 12 on O'Dwyer's roster of healthcare firms with 2021 fee income of $16.3M.
No comments have been submitted for this story yet.